🇺🇸 FDA
Patent

US 11104957

Compositions and methods for treating cancers

granted A61KA61K31/4745A61K31/706

Quick answer

US patent 11104957 (Compositions and methods for treating cancers) held by APTOSE BIOSCIENCES INC. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APTOSE BIOSCIENCES INC.
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4745, A61K31/706, A61K45/06, A61K49/0004